Patents by Inventor Magali Remaud-Simeon

Magali Remaud-Simeon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fully active alternansucrases partially deleted in its carboxy-terminal and amino-terminal domains and mutants thereof
    Patent number: 7524645
    Abstract: Nucleic acid sequences of truncated or mutated alternansucrases, vectors containing these nucleic acids sequences, host cells transformed with the nucleic acid sequences encoding truncated or mutated alternansucrases are provided. Furthermore, a process to recombinantly alternansucrase with a high level of expression, while retaining the enzymatic activity is described.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: April 28, 2009
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Pierre Monsan, Magali Remaud-Simeon, Gilles Joucla
  • Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2 osidic sidechains
    Publication number: 20060210510
    Abstract: The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with ?(1?2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
    Type: Application
    Filed: March 18, 2002
    Publication date: September 21, 2006
    Inventors: Sophi Anne Bozonnet, Magali Remaud-Simeon, Rene-Marc Willemot, Pierre Monsan
  • Fully active alternansucrases partially deleted in its carboxy-terminal and amino-terminal domains and mutants thereof
    Publication number: 20060127328
    Abstract: Nucleic acid sequences of truncated or mutated alternansucrases, vectors containing these nucleic acids sequences, host cells transformed with the nucleic acid sequences encoding truncated or mutated alternansucrases are provided. Furthermore, a process to recombinantly alternansucrase with a high level of expression, while retaining the enzymatic activity is described.
    Type: Application
    Filed: December 14, 2004
    Publication date: June 15, 2006
    Inventors: Pierre Monsan, Magali Remaud-Simeon, Gilles Joucla
  • Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes
    Publication number: 20060100172
    Abstract: The invention relates to the use of prebiotics for the preparation of food or pharmaceutical compositions which are intended for the treatment and/or prevention of hyperglycaemic syndromes and, in particular, for the treatment of Type II diabetes and/or the prevention of the onset of Type II diabetes in patients with a predisposition to developing the type of diabetes. The invention also relates to the food and pharmaceutical compositions containing the prebiotics.
    Type: Application
    Filed: September 12, 2003
    Publication date: May 11, 2006
    Applicant: Institut National De La Recherche Agronomique
    Inventors: Pierre Monsan, Philippe Valet, Magali Remaud-Simeon, Jean-Sebastien Saulnier-Blanche